tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Financial Statements

163 Followers

Conduit Pharmaceuticals Financial Overview

Conduit Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.21; its P/E ratio is -0.44; Conduit Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.34M$ 2.48M$ 2.11M$ 2.03M$ -2.07M
EBITDA$ -4.90M$ 2.90M$ 2.11M$ 2.03M$ -2.07M
Net Income Common Stockholders$ -5.38M$ -3.60M$ -1.89M$ 1.99M$ -2.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 414.00K$ 1.84M$ 4.23M$ 8.64M$ 277.76K
Total Assets$ 3.31M$ 4.92M$ 7.22M$ 12.02M$ 23.69M
Total Debt$ 1.27M$ 495.00K$ 185.00K$ 177.00K$ 750.00K
Net Debt$ 854.00K$ -1.35M$ -4.04M$ -8.47M$ 472.24K
Total Liabilities$ 8.77M$ 8.02M$ 7.68M$ 13.10M$ 6.66M
Stockholders Equity$ -5.46M$ -3.10M$ -457.00K$ -1.08M$ -6.07M
Cash Flow-
Free Cash Flow$ -1.51M$ -2.40M$ -4.80M$ -1.68M$ -431.00K
Operating Cash Flow$ -1.50M$ -2.40M$ -4.80M$ -1.68M$ -431.00K
Investing Cash Flow$ -224.00K-$ 497.00K$ -114.24M$ 404.00K
Financing Cash Flow$ 113.00K-$ -414.00K$ 124.66M$ 11.00K
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

Conduit Pharmaceuticals Debt to Assets

Conduit Pharmaceuticals Cash Flow

Conduit Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis